Are there targeted drugs for gastric cancer treatment? There are three types

Gastric cancer targeted drugs include anti-HER2 gene drugs, including trastuzumab. When the anti-HER2 gene is positive, trastuzumab can be used in chemotherapy to increase the chemotherapy effect; there are also anti-EGFR gene therapy drugs. For example, apatinib and ramucirumab are immune targeted drugs used as third-line treatments for advanced gastric cancer. There are many such drugs.

Gastric cancer is a very serious disease. Once it occurs, it will endanger the patient's life. Therefore, timely and effective treatment is very important. Under the current medical technology conditions, there are many drugs that can treat such diseases, including genetic drugs. So let's take a look at this, are there any targeted drugs for the treatment of gastric cancer?
1. Targeted drugs for gastric cancer include trastuzumab, etc. Anti-HER2 gene therapeutic drugs include trastuzumab. When the HER2 gene is positive during treatment, it can be used in combination with trastuzumab to increase the chemotherapy effect of patients; and anti-EGFR gene drugs, such as apatinib, are generally used in the late stage of gastric cancer and are used as the third-line standard treatment.
2. Immune targeted drugs used include Ramucirumab, etc. <br/>There are many immune targeted drugs, for example, anti-PD-1 is currently widely used, but PD-1 has not yet been launched in China. This drug is mainly for PD-1 antibody treatment; there are also other drugs, such as Ramucirumab and other drugs.
3. There is also apatinib and other targeted drugs and carriers that release the most effective ingredients at specific sites, which can kill tumor cells in the body and eliminate the tumor. The side effects are generally mild, and the treatment effect is very good. Commonly used targeted drugs for gastric cancer: Trastuzumab is suitable for people with gastric cancer whose factor receptors are positive when the body's epidermal cells grow; and apatinib is a multi-target small molecule targeted drug, which is developed domestically and has been certified by the FDA. It can be used by patients after the failure of second-line chemotherapy for gastric cancer; and ramucirumab is also good. This is an anti-angiogenic drug that can block oxygen and nutrient intake, shrinking and eliminating tumors. The main target of this drug is VEGFR. When using it, there is no need to conduct genetic testing. It can be applied directly, and the effect is very good.
The above is about the types of targeted drugs used in the treatment of gastric cancer, including apatinib, and immune targeted therapy drugs such as ramucirumab and trastuzumab, which have good therapeutic effects. When one of the drugs is not effective, other drugs can be used for treatment. There are many such targeted drugs.